Navigation Links
ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2008 Financial Results
Date:2/19/2009

er 31, 2008, was $1.9 million (or $0.06 per share) and $30.7 million (or $0.93 per share), respectively, compared with a net loss of $9.9 million (or $0.30 per share) and $38.2 million (or $1.29 per share) for the same periods in 2007. At December 31, 2008, ISTA had cash and short-term investments of $53.0 million.

2009 Financial Outlook

  • We expect our net revenue for 2009 will be approximately $92 to $97 million. We do not expect a generic to Xibrom in 2009. Our net sales are seasonal, with first quarter net sales typically being the lowest of the year and less than the prior quarter.
  • We expect our gross margin to be 70% to 73% in 2009. We expect our gross margin to be at the lower end at the beginning of the year and increasing to the higher end by year end 2009, due to the timing of certain manufacturing expenses in 2009.
  • We expect to be approximately operating income breakeven in 2009.
  • We expect our net loss for 2009 will be approximately $7 to $10 million, due to interest and related expenses.
  • Depending upon the progress of our clinical and pre-clinical programs, we expect our research and development expenses in 2009 to be in the range of $20 to $25 million and include costs associated with supporting the Bepreve NDA filing, milestones we have paid or expect to pay to Senju for the acceptance and approval of Bepreve, the Xibrom QD confirmatory study, T-Pred study completion, and a low-concentration version of Xibrom for dry eye.
  • We expect to end 2009 with a cash balance of $35 to $45 million, including cash drawn on our Silicon Valley Bank revolving credit facility, subject to change due to fluctuations in working capital.

Conference Call

ISTA will host a conference call with a simultaneous webcast today, February 19, 2009, at 5:00 PM Eastern Time, to discuss its fourth qu
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 30, 2015 , ... New research finds some distinct differences in ... more on the Surviving Mesothelioma website. , Researchers with the National Institutes ... than 12,000 cases of mesothelioma occurring between 1990 and 2010. Two percent of these ...
(Date:7/30/2015)... ... July 30, 2015 , ... Bird B Gone, the leader in bird ... system to repel pest birds from the AC units and ventilation systems on ... and toxoplasmosis, even the West Nile virus. When these droppings dry, the fine powder ...
(Date:7/30/2015)... ... July 30, 2015 , ... Author Dr. Raul Llanos ... their health in his new self-help book, “ Consciously Healing our Webs of Health, ... a simple message: “If we take responsibility for ourselves, we can create better realities.” ...
(Date:7/30/2015)... ... July 30, 2015 , ... After conducting a nationwide executive search ... Episcopal Hospital in Far Rockaway, N.Y., has hired Gerard (Jerry) Walsh as Chief ... 25 years of healthcare leadership experience, Walsh is an expert in organizational change, physician ...
(Date:7/30/2015)... ... , ... After a three year trial designed to study the efficiency and ... “bionic eye,” researchers have determined the trial to be a success, and are recommending ... affected by complete vision loss as a result of Retinitis pigmentosa. The results of ...
Breaking Medicine News(10 mins):Health News:Study Finds Mesothelioma Behaves Differently in Younger People, According to Surviving Mesothelioma 2Health News:Bird B Gone’s New Bird Hazing System Keeps Disease-Carrying Bird Droppings Out of Hospitals 2Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 2Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 3Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 2Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 3Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 4Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 5Health News:The Vision Enhancing “Bionic Eye” Deemed Safe For Long Term Use After Three Year Clinical Trial 2
... Ten years after the then US President set a target ... remains a distant dream . ,"We have learned ... is," says immunologist Wayne Koff, senior vice president for research ... ,Global spending for HIV vaccine research increased from $186 ...
... of botched up surgeries generally suffer in silence, cough up more ... with mixed results. ,And here comes the news that ... workmanship, charging a flat fee that includes 90 days of follow-up ... to come back to the hospital, it would not to send ...
... vaccine Gardasil is effective in preventing vaginal and vulvar tumors, ... in the journal Lancet, Dow Jones reports. ,Gardasil ... in preventing infection with strains 16 and 18, which together ... effective in preventing HPV strains 6 and 11, which together ...
... Zimbabwes Minister of Health and Child Welfare, Dr. David ... by the West have severely compromised the country's ... to the ongoing World Health Assembly in Geneva, Switzerland, ... lifting of these sanctions. He calls the sanctions ...
... Most of the people who are affected by chronic ... those with herniated discs , spinal stenosis, and complications ... used for treating chronic back pain is considered unsuitable ... earlier work, a new study led by Dr. David ...
... U.S. Department of Veterans Affairs, in response to numerous complaints ... up an outpatient clinic in Evansville city that would ... VA is seeking about 87,000 square feet that must be ... have complained for nearly two years about the quality of ...
Cached Medicine News:Health News:AIDS Vaccine Still a Long Way Off 2Health News:US Hospital Group Offers Warranty on Surgeries 2Health News:US Hospital Group Offers Warranty on Surgeries 3Health News:Sanctions Imposed On Zimbabwe Can Threaten International Health Security 2
(Date:7/30/2015)... 2015 P&S Market ... market overview, trends, DRO analysis, market segmentation, ... developments, competitive scenario and top competitor profiles ... Market Development and Demand Forecast to 2020  ... Explore more about global biosensors ...
(Date:7/30/2015)... SAN FRANCISCO , July 30, 2015 ... devices market is expected to reach USD 23.01 ... Grand View Research, Inc. Growing base of geriatric population, ... and infections, and rising level of awareness among target ... impact rendering drivers over the forecast period. According to ...
(Date:7/30/2015)... 30, 2015  Lannett Company, Inc. (NYSE: LCI ... the Canaccord Genuity 35th Annual Growth Conference on Wednesday, ... InterContinental Boston Hotel.  A webcast of ... Listeners are encouraged to visit the web site at ... presentation to register, download and install any necessary software.  ...
Breaking Medicine Technology:Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 5ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 2ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 4ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 5
... American Pharmacists Association (APhA) is encouraging consumers to get ... as the site to receive their vaccine. Pharmacists in ... authorized to administer influenza vaccines and, as of June ... trained to administer immunizations. "The pharmacist is ...
... Exceptionally high costs.  Long research and development cycles.  Low ...  Dependence on out-dated information technology options.  It,s not just ... information being wasted.   Such ... have led to the formation of a new company, ...
Cached Medicine Technology:Consumers Encouraged to Get Immunized Against Influenza 2RedOak Logic's Mission: Transform Pharmaceutical Industry Drug Development 2RedOak Logic's Mission: Transform Pharmaceutical Industry Drug Development 3RedOak Logic's Mission: Transform Pharmaceutical Industry Drug Development 4
Complete cytology platform....
... PFO closure, the Premere PFO,Closure System from ... more confident PFO closure procedures. Conformable Anchors, ... to anatomy , Anchors are thin and ... Anchors can be brought together gradually for ...
The most compact revolutionary innovation in hematology. 3 Part DIFF + CRP measurement on whole blood....
... The Inspirex Sleep System is an easy-to-use, workflow-based ... your results. Inspirex consists of the SleepWorks ... These rugged and durable systems can be ... and ambulatory studies - including full EEG recording ...
Medicine Products: